Novus Biologicals, LLC
PO Box 802; Littleton, CO, 80160 USA
Phone: 303.730.1950 Fax: 303.730.1966


14-3-3 Antibody (NB100-2140)

14-3-3 Antibody

Catalog#: NB100-2140 100% Guarantee
This product is fully covered under guarantee+
Storage: Store at 4C. Do not freeze.
Buffer: 0.2% Gelatin, PBS
Preservative: 0.1% Sodium Azide
Purity: Immunogen affinity purified
Host: Rb
Clonality: Polyclonal
Specificity: Broadly reactive among the 14-3-3 family. This recognizes alpha, beta, zeta (delta) and theta 14-3-3.
Modification: No
Isotype: IgG
Immunogen: Synthetic peptide mapping to the amino terminal domain of human 14-3-3.
Entrez: 10971 (Human)
Related Genes: 10971
Background:
14-3-3 family of proteins is composed of seven isotypes, beta, gamma, zeta, epsilon, tau, eta, and sigma, that play critical roles in cell signaling events that control cell cycle progression, transcriptional alterations, and apoptosis (1-4). 14-3-3 proteins were the first signaling molecules to be identified as specific phosphoserine/threonine binding proteins (1). 14-3-3 can serve as a direct regulator of its target by altering the function of the protein (3). 14-3-3 protein targets include the signalling intermediates Raf, MEKK, PI-3 kinase and IRS-1, cell cycle proteins CDK2, Wee1, and Cdc25, and apoptosis proteins BAD and ASK-1 (3,4).
Rt, Mu, Hu
reactivity: Cross-reacts with Human, Mouse and Rat. Not yet tested in other species..
WB, IP, IHC
Uses: This antibody is useful for Immunohistochemistry, Immunoprecipitation and Western Blot.
Dilutions: immunohistochemistry , immunoprecipitation , Western Blot 1/400
Positive Controls: Hela Whole Cell Lysate (Hela Whole Cell Lysate (NB800-PC1) (1mg)) Jurkat Whole Cell Lysate (Jurkat Whole Cell Lysate (NB800-PC2)(0.5mg)) 14-3-3 Lysate (14-3-3 Lysate (NBL1-17951)(0.1mg))
Publications: Yaffe MB. 2002. How do 14-3-3 proteins work?- - Gatekeeper phosphorylation the molecular anvil hypothesis. FEBS Lett. 513(1):53-57. Liu MY, Cai S, Espejo A, Bedford MT, Walker CL. 2002. 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation sites. Cancer Res. 62(22): 6475-6480. Tzivion G, Shen YH, Zhu J. 2001. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 20(44):6331-6338.
Reviews
No reviews have been submitted for this product.

Working with 14-3-3

Publications (4)
General:

Yaffe MB. 2002. How do 14-3-3 proteins work?- - Gatekeeper phosphorylation the molecular anvil hypothesis. FEBS Lett. 513(1):53-57.

Liu MY, Cai S, Espejo A, Bedford MT, Walker CL. 2002. 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation sites. Cancer Res. 62(22): 6475-6480.

Tzivion G, Shen YH, Zhu J. 2001. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 20(44):6331-6338.

4 general publications available on website.


 
Images (1)